BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 119365
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.119365
Table 1 Differences in indicator levels between healthy control group and lung cancer group
Indicator
Healthy control group (n = 143)
Lung cancer group (n = 113)
CEA (ng/L)1.55 (0.98, 2.29)3.40 (1.69, 8.43)
CY211 (ng/mL)1.65 (1.22, 2.21)2.55 (1.76, 3.13)
NSE (ng/mL)9.46 (8.25, 10.78)10.79 (8.03, 12.48)
GM-CSF (pg/mL)0.72 (0.35, 1.75)1.42 (0.82, 2.50)
IL-10 (pg/mL)1.98 (1.16, 3.05)1.11 (0.81, 1.70)
IL-8 (pg/mL)17.12 (8.40, 38.69)315.75 (160.44, 523.19)
MCP-1 (pg/mL)341.11 (258.94, 500.58)636.03 (506.75, 859.70)
TNF-α (pg/mL)5.94 (4.62, 7.68)19.33 (12.77, 30.34)
Table 2 Diagnostic value of carcinoembryonic antigen, cytokeratin 19 fragment, neuron-specific enolase, interleukin-8, monocyte chemoattractant protein-1, and tumor necrosis factor-alpha
Indicator
AUC (95%CI)
P value
Cut-off value
Sensitivity (%)
Specificity (%)
CEA0.755 (0.694-0.816)< 0.0012.8572.681.1
CY2110.703 (0.639-0.767)< 0.0012.2668.174.8
NSE0.587 (0.514-0.661)0.01710.1056.667.1
IL-80.957 (0.935-0.978)< 0.001126.2593.894.4
MCP-10.825 (0.772-0.877)< 0.001427.6486.788.1
TNF-α0.936 (0.907-0.965)< 0.0019.8589.490.9
Table 3 Odds ration of the indicators in the binary analysis
Indicator
β
SE
Wals
P value
Exp(B)
95%CI
Lower
Upper
CEA0.3710.1357.5250.0061.4491.1121.888
CY2110.5180.2066.3380.0121.6781.1222.512
IL-80.0140.00325.746< 0.0011.0141.0091.020
TNF-α0.1000.0406.1250.0131.1051.0211.196